ANTXR1 Gene Hemangioma Capillary Infantile Genetic Test sale cost 4400 AED
CCND1 Gene Colorectal Cancer Hereditary Susceptibility to Genetic Test sale cost 4400 AED CCND1 Gene Colorectal Cancer Hereditary Susceptibility to Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
MN1 Gene Meningioma MN1 Deficiency Related Genetic Test sale cost 4400 AED MN1 Gene Meningioma MN1 Deficiency Related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ANTXR1 Gene Hemangioma Capillary Infantile Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “ANTXR1 Gene Hemangioma Capillary Infantile Genetic Test” is a specialized diagnostic procedure aimed at identifying mutations in the ANTXR1 gene, which are associated with the development of infantile capillary hemangiomas. These are benign vascular tumors that usually appear in early childhood and can cause various complications depending on their size and location. The test involves analyzing the patient’s DNA to detect any genetic anomalies linked to this condition, offering crucial information for early diagnosis and management.

Performed at DNA Labs UAE, a leading facility in genetic testing, this test is priced at 4400 AED. The laboratory utilizes advanced genomic technologies to ensure accurate and reliable results, aiding in the formulation of targeted treatment plans. This test is particularly valuable for families with a history of capillary hemangiomas, as it can help in predicting the likelihood of occurrence in infants, facilitating early interventions that can significantly improve outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ANTXR1 Gene Hemangioma capillary infantile Genetic Test

At DNA Labs UAE, we offer the ANTXR1 Gene Hemangioma capillary infantile Genetic Test for the diagnosis of infantile hemangioma. This test helps in identifying any genetic variations or mutations in the ANTXR1 gene that may be associated with the development of hemangiomas in infants.

Test Components and Price

The ANTXR1 Gene Hemangioma capillary infantile Genetic Test is priced at 4400.0 AED. The test can be performed using blood or extracted DNA, or even a single drop of blood on an FTA card.

Report Delivery and Method

After the sample is collected, the report will be delivered within 3 to 4 weeks. The test is conducted using NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes or the entire genome.

Test Type and Doctor

The ANTXR1 Gene Hemangioma capillary infantile Genetic Test falls under the category of cancer genetic testing. It is recommended to consult with an oncologist for this test.

Test Department and Pre Test Information

This test is conducted by our Genetics department. Before undergoing the ANTXR1 Gene Hemangioma capillary infantile Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with the ANTXR1 Gene Hemangioma capillary infantile NGS Genetic DNA Test gene ANTXR1.

Test Details

The ANTXR1 gene is associated with infantile hemangioma, a type of benign tumor that commonly occurs in infants. Hemangiomas are characterized by abnormal growth of blood vessels in the skin or internal organs. The NGS genetic testing method helps in identifying genetic variations or mutations in the ANTXR1 gene that may contribute to the development of hemangiomas in infants.

This genetic test is useful in confirming a diagnosis of infantile hemangioma, determining the risk of developing the condition, and guiding appropriate management and treatment strategies. It also provides valuable information for genetic counseling and family planning purposes.

Test Name ANTXR1 Gene Hemangioma capillary infantile Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ANTXR1 Gene Hemangioma capillary infantile NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ANTXR1 Gene Hemangioma capillary infantile NGS Genetic DNA Test gene ANTXR1
Test Details

The ANTXR1 gene is associated with a condition called infantile hemangioma, which is a type of benign tumor that typically occurs in infants. Hemangiomas are characterized by an abnormal growth of blood vessels in the skin or internal organs.

NGS (Next-Generation Sequencing) genetic testing refers to a method of DNA sequencing that allows for the simultaneous analysis of multiple genes or the entire genome. In the context of the ANTXR1 gene and infantile hemangioma, NGS genetic testing can be used to identify any genetic variations or mutations in the ANTXR1 gene that may be associated with the development of hemangiomas in infants.

This type of genetic testing can help in confirming a diagnosis of infantile hemangioma, determining the risk of developing the condition, and guiding appropriate management and treatment strategies. It may also provide valuable information for genetic counseling and family planning purposes.

SKU: TEST-4492 Category:

Related products